Fiducial markers are mainly used in radiotherapy treatment of cancer. These markers are placed near the tumor to mark the area to be radiated. This prevents the damage to good tissues during the therapy. This is an image-guided procedure and guides the doctor to provide the accurate dose of radiation.

The major attributes propelling the market growth include the growing preference of radiotherapy devices by oncologists and increasing funding by public and private sectors for the market enhancement. Somehow, the complexities in the procedure of implanting the fiducial markers are impeding the market.

Request for sample report @ https://www.infoholicresearch.com/request-a-sample-report/?repid=14600

The market research report titled “Fiducial Markers Market by Cancer Type, Product, End-User, Modality, and Geography – Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2026” gives in-depth and actionable market insights to enable improved growth for its readers.

Followed by North America, the Asia Pacific region as well anticipated to grow during the forecast period. The rising support of the government by taking initiatives for better improvement in the healthcare sector structure coupled with growing cases of cancer in this region is fuelling the growth in the region. Further, the adoption of radiotherapy treatment in this region also contributing to the growth of the market.

CIVCO RADIOTHERAPY, Boston Scientific Corporation, IZI Medical Products, Naslund Medical AB, Best Medical International, Inc., and Carbon Medical Technologies are the major companies responsible for market enhancement.

Access full report summary @ https://www.infoholicresearch.com/report/fiducial-markers-market/

The Fiducial Markers market can be analyzed on the market based on:

Cancer Type:

• Prostate Cancer      
• Lung Cancer            
• Breast Cancer
• Gastric Cancer
• Other Cancers

Product:

• Metal-based Markers         

• Pure Gold           
• Gold Alloys
• Other Metal-based Markers

• Other Fiducial Markers

End-User:

• Hospitals & Outpatient Facilities            
• Independent Radiotherapy Centers                    
• Cancer Research Centers  

Modality:

• CT/CBCT      
• MRI
• Ultrasound
• Radiotherapy

Geography:

• North America
• Europe
• Asia Pacific
• Rest of the World